BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11756856)

  • 1. Seesaw nystagmus following whole brain irradiation and intrathecal methotrexate.
    Epstein JA; Moster ML; Spiritos M
    J Neuroophthalmol; 2001 Dec; 21(4):264-5. PubMed ID: 11756856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial tumor lysis and cerebral edema after administration of intrathecal methotrexate: a case report and discussion.
    Bachegowda LS; Grivas PD; Anand R; Stecker E; Ward K
    Med Oncol; 2010 Dec; 27(4):1079-81. PubMed ID: 19847678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior reversible encephalopathy after intrathecal methotrexate therapy in diffuse large B-cell lymphoma.
    Patel A; Ayto R; MacDonald DH
    Br J Haematol; 2013 Jun; 161(5):607. PubMed ID: 23617825
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis.
    Chan YL; Roebuck DJ; Yuen MP; Yeung KW; Lau KY; Li CK; Chik KW
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):759-63. PubMed ID: 11395245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of reversible cerebral neurotoxicity and irreversible cerebellar atrophy following an intrathecal methotrexate chemotherapy: two case reports.
    Masterson K; Merlini L; Lövblad KO
    J Neuroradiol; 2009 May; 36(2):112-4. PubMed ID: 18722663
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate-induced periorbital radiation recall.
    Kiel PJ; Jones KL
    Ann Pharmacother; 2011 Jan; 45(1):133. PubMed ID: 21205951
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracerebral hematoma as a complication of intrathecal methotrexate administration.
    Boran P; Tokuc G; Boran BO; Oktem S
    Pediatr Blood Cancer; 2008 Jan; 50(1):152-4. PubMed ID: 16615061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma.
    Elkiran ET; Altundag K; Aksoy S; Onal IK; Tekuzman G
    Am J Hematol; 2004 Apr; 75(4):265. PubMed ID: 15054831
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL).
    Weigel R; Senn P; Weis J; Krauss JK
    Clin Neurol Neurosurg; 2004 Mar; 106(2):82-7. PubMed ID: 15003295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation.
    Higuchi M; Hata T; Furuya S; Hosaka S; Kamijo Y; Kiyosawa K; Ishizuka O; Nishizawa O; Hora K
    Nephrology (Carlton); 2005 Jun; 10(3):321-4. PubMed ID: 15958050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral subdural hygromas following intrathecal methotrexate.
    Lokireddy P; Dyer MJ
    Br J Haematol; 2011 Dec; 155(5):536. PubMed ID: 21923656
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas.
    Hiraga S; Arita N; Ohnishi T; Kohmura E; Yamamoto K; Oku Y; Taki T; Sato M; Aozasa K; Yoshimine T
    J Neurosurg; 1999 Aug; 91(2):221-30. PubMed ID: 10433310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.
    Hogan MP; Osborne J; Ulaner GA
    Clin Nucl Med; 2016 Dec; 41(12):995-997. PubMed ID: 27805919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal methotrexate-induced acute chorea.
    Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary central nervous system lymphoma: long-term survival following treatment with radiation and methotrexate.
    Petursson SR
    Eur J Surg Oncol; 1989 Feb; 15(1):69-72. PubMed ID: 2645176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal methotrexate-induced acute cerebellar syndrome.
    Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
    Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Goldstein DA; Tessler HH
    Am J Ophthalmol; 2007 Dec; 144(6):976; author reply 976. PubMed ID: 18036877
    [No Abstract]   [Full Text] [Related]  

  • 19. Cured of acute lymphoblastic leukaemia but lost for words.
    Winter E; Prendergast M
    Neuropediatrics; 1995 Oct; 26(5):267-9. PubMed ID: 8552219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
    Singhal D; Witham TF; Germanwala A; Flickinger JC; Schiff D; Kondziolka D
    Can J Neurol Sci; 2002 May; 29(2):147-53. PubMed ID: 12035835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.